Moreover, PITPNA-AS1 was also involved in the development of glioblastoma [13], hepatocellular carcinoma [14], triple-negative breast cancer [15], whereas, its application in prostate cancer has not been discussed yet and deserves further study. Here, PITPNA is linked to prostate carcinoma.